{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:41:24Z","timestamp":1792698084203,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Nantong Infectious Disease Prevention and Control Alliance Research Project","award":["No. NTCRB2025003"],"award-info":[{"award-number":["No. NTCRB2025003"]}]},{"name":"Nantong Science and Technology Bureau Projects","award":["No. MSZ2025090"],"award-info":[{"award-number":["No. MSZ2025090"]}]},{"name":"Nantong Science and Technology Bureau Projects","award":["No. JCZ2025002"],"award-info":[{"award-number":["No. JCZ2025002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Microbiol"],"DOI":"10.1007\/s10123-026-00911-3","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:47:32Z","timestamp":1792651652000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Modulation of anti-tuberculosis drug-induced liver injury by gut microbiota metabolites: Insights from network pharmacology"],"prefix":"10.1007","author":[{"given":"Mingyang","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiming","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"issue":"3","key":"911_CR1","doi-asserted-by":"publisher","first-page":"e70204","DOI":"10.1002\/ardp.70204","volume":"359","author":"Z Batool","year":"2026","unstructured":"Batool Z et al (2026) A Review on Isoniazid and Rifampicin-Associated Hepatotoxicity: From Metabolism to Immunity. Arch Pharm (Weinheim) 359(3):e70204","journal-title":"Arch Pharm (Weinheim)"},{"key":"911_CR5","doi-asserted-by":"publisher","first-page":"114984","DOI":"10.1016\/j.intimp.2025.114984","volume":"160","author":"W Chen","year":"2025","unstructured":"Chen W et al (2025) Mitophagy-mtROS axis contributes to anti-tuberculosis-induced liver injury through activation of the cGAS-STING pathway in rat hepatocytes. Int Immunopharmacol 160:114984","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"911_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/jleuko\/qiae049","volume":"116","author":"E Contreras-Castillo","year":"2024","unstructured":"Contreras-Castillo E et al (2024) Stability and plasticity of regulatory T cells in health and disease. J Leukoc Biol 116(1):33\u201353","journal-title":"J Leukoc Biol"},{"issue":"10","key":"911_CR33","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1136\/gut.28.10.1221","volume":"28","author":"JH Cummings","year":"1987","unstructured":"Cummings JH et al (1987) Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28(10):1221\u20131227","journal-title":"Gut"},{"issue":"4","key":"911_CR29","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/eji.201646394","volume":"47","author":"RS Czepielewski","year":"2017","unstructured":"Czepielewski RS et al (2017) GRPR antagonist protects from drug-induced liver injury by impairing neutrophil chemotaxis and motility. Eur J Immunol 47(4):646\u2013657","journal-title":"Eur J Immunol"},{"key":"911_CR21","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717","journal-title":"Sci Rep"},{"issue":"W1","key":"911_CR20","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/nar\/gkz382","volume":"47","author":"A Daina","year":"2019","unstructured":"Daina A, Michielin O, Zoete V (2019) SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res 47(W1):W357\u2013W364","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"911_CR22","doi-asserted-by":"publisher","first-page":"W422","DOI":"10.1093\/nar\/gkae236","volume":"52","author":"L Fu","year":"2024","unstructured":"Fu L et al (2024) ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support. Nucleic Acids Res 52(W1):W422\u2013W431","journal-title":"Nucleic Acids Res"},{"key":"911_CR4","doi-asserted-by":"publisher","first-page":"564580","DOI":"10.2147\/IDR.S564580","volume":"19","author":"K He","year":"2026","unstructured":"He K et al (2026) Common Adverse Reactions and Management Strategies of First-Line Anti-Tuberculosis Drugs. Infect Drug Resist 19:564580","journal-title":"Infect Drug Resist"},{"key":"911_CR8","doi-asserted-by":"crossref","unstructured":"Huang Y et al (2024) Role of gut microecology in the pathogenesis of drug-induced liver injury and emerging therapeutic strategies. Molecules 29(11)","DOI":"10.3390\/molecules29112663"},{"issue":"2","key":"911_CR19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nbt1284","volume":"25","author":"MJ Keiser","year":"2007","unstructured":"Keiser MJ et al (2007) Relating protein pharmacology by ligand chemistry. Nat Biotechnol 25(2):197\u2013206","journal-title":"Nat Biotechnol"},{"issue":"5","key":"911_CR3","doi-asserted-by":"publisher","first-page":"106618","DOI":"10.4254\/wjh.v17.i5.106618","volume":"17","author":"R Kumar","year":"2025","unstructured":"Kumar R, Kumar A, Kumar S (2025) Acute liver failure from anti-tuberculosis drug-induced liver injury: An update. World J Hepatol 17(5):106618","journal-title":"World J Hepatol"},{"issue":"8","key":"911_CR31","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.3390\/nu14081668","volume":"14","author":"Y Li","year":"2022","unstructured":"Li Y et al (2022) Lactobacillus casei Improve Anti-Tuberculosis Drugs-Induced Intestinal Adverse Reactions in Rat by Modulating Gut Microbiota and Short-Chain Fatty Acids. Nutrients 14(8):1668","journal-title":"Nutrients"},{"issue":"3","key":"911_CR24","doi-asserted-by":"publisher","first-page":"101355","DOI":"10.1016\/j.jcmgh.2024.05.003","volume":"18","author":"G Li","year":"2024","unstructured":"Li G et al (2024) Interplay Between Drug-Induced Liver Injury and Gut Microbiota: A Comprehensive Overview. Cell Mol Gastroenterol Hepatol 18(3):101355","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"911_CR27","doi-asserted-by":"publisher","first-page":"1538528","DOI":"10.3389\/fmed.2025.1538528","volume":"12","author":"Q Li","year":"2025","unstructured":"Li Q et al (2025) Bacteroides fragilis 839 ameliorates anti-tuberculosis drugs-induced liver injury by suppressing inflammation and regulating gut microbiota in mice. Front Med (Lausanne) 12:1538528","journal-title":"Front Med (Lausanne)"},{"issue":"W1","key":"911_CR23","doi-asserted-by":"publisher","first-page":"W159","DOI":"10.1093\/nar\/gkac394","volume":"50","author":"Y Liu","year":"2022","unstructured":"Liu Y et al (2022) CB-Dock2: improved protein\u2013ligand blind docking by integrating cavity detection, docking and homologous template fitting. Nucleic Acids Res 50(W1):W159\u2013W164","journal-title":"Nucleic Acids Res"},{"key":"911_CR7","doi-asserted-by":"publisher","first-page":"110439","DOI":"10.1016\/j.cbi.2023.110439","volume":"376","author":"Y Liu","year":"2023","unstructured":"Liu Y et al (2023) Hepatocyte ferroptosis contributes to anti-tuberculosis drug-induced liver injury: Involvement of the HIF-1\u03b1\/SLC7A11\/GPx4 axis. Chem Biol Interact 376:110439","journal-title":"Chem Biol Interact"},{"issue":"4","key":"911_CR12","doi-asserted-by":"publisher","first-page":"e70054","DOI":"10.1002\/imt2.70054","volume":"4","author":"Y Liu","year":"2025","unstructured":"Liu Y et al (2025) Gut microbiota and tuberculosis. Imeta 4(4):e70054","journal-title":"Imeta"},{"issue":"10","key":"911_CR30","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41579-025-01183-w","volume":"23","author":"I Mukhopadhya","year":"2025","unstructured":"Mukhopadhya I, Louis P (2025) Gut microbiota-derived short-chain fatty acids and their role in human health and disease. Nat Rev Microbiol 23(10):635\u2013651","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"911_CR25","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s40168-017-0286-2","volume":"5","author":"S Namasivayam","year":"2017","unstructured":"Namasivayam S et al (2017) Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy. Microbiome 5(1):71","journal-title":"Microbiome"},{"issue":"2","key":"911_CR10","doi-asserted-by":"publisher","first-page":"e0035323","DOI":"10.1128\/mbio.00353-23","volume":"14","author":"S Namasivayam","year":"2023","unstructured":"Namasivayam S et al (2023) The Dysbiosis Triggered by First-Line Tuberculosis Antibiotics Fails to Reduce Their Bioavailability. mBio 14(2):e0035323","journal-title":"mBio"},{"issue":"1","key":"911_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21691401.2022.2155661","volume":"51","author":"KK Oh","year":"2023","unstructured":"Oh KK et al (2023) New insight into gut microbiota-derived metabolites to enhance liver regeneration via network pharmacology study. Artif Cells Nanomed Biotechnol 51(1):1\u201312","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"11","key":"911_CR14","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.1111\/cas.15142","volume":"112","author":"N Ohtani","year":"2021","unstructured":"Ohtani N, Hara E (2021) Gut-liver axis-mediated mechanism of liver cancer: A special focus on the role of gut microbiota. Cancer Sci 112(11):4433\u20134443","journal-title":"Cancer Sci"},{"key":"911_CR28","doi-asserted-by":"publisher","first-page":"1512815","DOI":"10.3389\/fphar.2025.1512815","volume":"16","author":"S Pei","year":"2025","unstructured":"Pei S et al (2025) The association between the gut microbiome and antituberculosis drug-induced liver injury. Front Pharmacol 16:1512815","journal-title":"Front Pharmacol"},{"issue":"2","key":"911_CR6","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3109\/03602532.2014.984070","volume":"47","author":"DA Perwitasari","year":"2015","unstructured":"Perwitasari DA, Atthobari J, Wilffert B (2015) Pharmacogenetics of isoniazid-induced hepatotoxicity. Drug Metab Rev 47(2):222\u2013228","journal-title":"Drug Metab Rev"},{"issue":"D1","key":"911_CR18","doi-asserted-by":"publisher","first-page":"D783","DOI":"10.1093\/nar\/gkae1002","volume":"53","author":"C Qi","year":"2025","unstructured":"Qi C et al (2025) gutMGene v2.0: an updated comprehensive database for target genes of gut microbes and microbial metabolites. Nucleic Acids Res 53(D1):D783\u2013D788","journal-title":"Nucleic Acids Res"},{"key":"911_CR15","doi-asserted-by":"publisher","first-page":"1539972","DOI":"10.3389\/fmicb.2025.1539972","volume":"16","author":"X Qin","year":"2025","unstructured":"Qin X et al (2025) Role of short-chain fatty acids in non-alcoholic fatty liver disease and potential therapeutic targets. Front Microbiol 16:1539972","journal-title":"Front Microbiol"},{"issue":"2","key":"911_CR2","doi-asserted-by":"publisher","first-page":"116","DOI":"10.4103\/ijmy.ijmy_15_21","volume":"10","author":"SS Raj Mani","year":"2021","unstructured":"Raj Mani SS et al (2021) Predicting antitubercular drug-induced liver injury and its outcome and introducing a novel scoring system. Int J Mycobacteriol 10(2):116\u2013121","journal-title":"Int J Mycobacteriol"},{"issue":"2","key":"911_CR9","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.3390\/cimb46020078","volume":"46","author":"W Tao","year":"2024","unstructured":"Tao W, Fan Q, Wei J (2024) Gut-Liver Axis as a Therapeutic Target for Drug-Induced Liver Injury. Curr Issues Mol Biol 46(2):1219\u20131236","journal-title":"Curr Issues Mol Biol"},{"key":"911_CR26","doi-asserted-by":"publisher","first-page":"1127916","DOI":"10.3389\/fcimb.2023.1127916","volume":"13","author":"C Wu","year":"2023","unstructured":"Wu C et al (2023) Effects of second-line anti-tuberculosis drugs on the intestinal microbiota of patients with rifampicin-resistant tuberculosis. Front Cell Infect Microbiol 13:1127916","journal-title":"Front Cell Infect Microbiol"},{"key":"911_CR32","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/bs.mie.2021.11.012","volume":"664","author":"X Yang","year":"2022","unstructured":"Yang X, Zhang ZJ, Hang HC (2022) Chemical proteomics for identifying short-chain fatty acid modified proteins in Salmonella. Methods Enzymol 664:135\u2013150","journal-title":"Methods Enzymol"},{"issue":"1","key":"911_CR17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s10020-024-01033-0","volume":"30","author":"W Yao","year":"2024","unstructured":"Yao W et al (2024) Elucidating the role of gut microbiota metabolites in diabetes by employing network pharmacology. Mol Med 30(1):263","journal-title":"Mol Med"},{"issue":"11","key":"911_CR13","doi-asserted-by":"publisher","first-page":"113756","DOI":"10.4254\/wjh.v17.i11.113756","volume":"17","author":"CY Zhang","year":"2025","unstructured":"Zhang CY et al (2025) Roles of short-chain fatty acids in metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis. World J Hepatol 17(11):113756","journal-title":"World J Hepatol"}],"container-title":["International Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10123-026-00911-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10123-026-00911-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10123-026-00911-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:01:57Z","timestamp":1792695717000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10123-026-00911-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":33,"alternative-id":["911"],"URL":"https:\/\/doi.org\/10.1007\/s10123-026-00911-3","relation":{},"ISSN":["1618-1905"],"issn-type":[{"value":"1618-1905","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]},"assertion":[{"value":"23 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study did not require ethical approval, as it exclusively used computational analyses of data from public repositories and did not involve any human or animal subjects.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}